Critical information about the dangers of ibogaine treatment and who should avoid it entirely.
Ibogaine can be fatal. Deaths have occurred during and after ibogaine treatment. The primary cause is cardiac arrhythmia, particularly in individuals with pre-existing heart conditions or those taking certain medications.
Never take ibogaine without proper medical screening and supervision. Self-administration or treatment at improperly equipped facilities can result in death.
Ibogaine is not a casual psychedelic like psilocybin or LSD. It has significant physiological effects on the cardiovascular system and can be dangerous for certain individuals. The risks are real and must be taken seriously.
Ibogaine affects the heart's electrical system in ways that can be dangerous:
Deaths from ibogaine have been documented. A 2020 review identified over30 reported deaths associated with ibogaine use, most involving cardiac complications or pre-existing conditions that should have excluded ibogaine treatment. According to research published in the Journal of Psychopharmacology, proper medical screening could have prevented many of these deaths.
Absolute Contraindications — These conditions make ibogaine treatment dangerous and it should be avoided entirely:
These conditions require careful evaluation and may or may not exclude treatment:
Certain medications are extremely dangerous when combined with ibogaine. This is one of the most critical safety issues and has contributed to multiple deaths.
Most treatment centers require:
Given the risks, selecting a reputable treatment center is critical. Here's what to look for:
Avoid any center that:
Before committing to treatment, ask these questions directly and expect clear answers:
If a center cannot or will not answer these questions, find another facility. Your life is worth more than convenience or cost savings.
Ibogaine carries real, potentially fatal risks—primarily cardiac complications. However, with proper medical screening and supervised treatment, deaths are rare. The key is eliminating contraindications through ECG screening and avoiding patients with heart conditions, liver/kidney disease, or dangerous medication interactions.
Absolutely not. Deaths have occurred when people attempted self-administration without medical supervision. Ibogaine affects the heart, causes severe ataxia (loss of motor control), and can last24-48 hours. You need trained staff monitoring vital signs continuously.
Reputable treatment centers require: ECG (electrocardiogram) to check heart rhythm, comprehensive blood panel including liver and kidney function, medical history review, and often drug screening. Never skip these tests—they identify contraindications that could be fatal.
Never combine ibogaine with: methadone, buprenorphine/Suboxone, SSRIs/SNRIs/MAOIs (antidepressants), antipsychotics, heart medications, benzodiazepines, or stimulants. Deaths have occurred from these interactions. Always disclose all medications to treatment providers.